Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

MRTXMRTX
22 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in MIRATI THERAPEUTICS INC

As of its Q4 2023 13F, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS held 65,534 shares of MRTX (Mirati Therapeutics), worth $3.9M. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS' 13F filings listed MRTX from Q4 2018 to Q4 2023, 21 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$291,850

Total Shares Change

-6,880

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2023-Q4
Decreased
65,534
-78.0%
$3.9M0.0%—
0
2023-Q3
Decreased
298,194
-1.5%
$13M0.0%—
0
2023-Q2
Unchanged
302,821
0.0%
$11.3M0.0%—
0
2023-Q1
Increased
302,821
+26.2%
$11.3M0.0%—
34
2022-Q4
Increased
239,902
+18.8%
$10.9M0.0%—
33
2022-Q3
Decreased
201,926
-7.1%
$14.1M0.0%—
0
2022-Q2
Decreased
217,419
-24.4%
$14.6M0.0%—
0
2022-Q1
Decreased
287,660
-46.2%
$23.7M0.0%—
0
2021-Q4
Increased
535,065
+31.5%
$78.5M0.0%—
38
2021-Q3
Decreased
407,000
-5.5%
$72M0.0%—
0
2021-Q2
Decreased
430,751
-7.2%
$69.6M0.0%—
0
2021-Q1
Decreased
464,090
-5.7%
$79.5M0.0%—
0
2020-Q4
Decreased
492,016
-23.9%
$108.1M0.1%—
0
2020-Q3
Increased
646,296
+6.9%
$107.3M0.1%—
32
2020-Q2
Increased
604,650
+1.0%
$69M0.0%—
30
2020-Q1
Increased
598,463
+64.2%
$46M0.0%—
43
2019-Q4
Increased
364,532
+54.7%
$47M0.0%—
41
2019-Q3
Increased
235,593
+976.9%
$18.4M0.0%—
46
2019-Q2
Increased
21,877
+103.3%
$2.3M0.0%—
42
2019-Q1
Increased
10,760
+56.4%
$788,7090.0%—
35
2018-Q4
First report
6,880
-
$291,8500.0%—
0

Other major holders of MRTX: Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used